Authors:
KHAYAT D
BANZET P
WEIL M
FUMOLEAU P
AVRIL MF
NAMER M
BONNETERRE J
KERBRAT P
BONERANDI JJ
BUGAT R
MONTCUQUET P
CUPISSOL D
LAUVIN R
VILMER C
BOAZIZ C
COUR V
BIZZARI JP
Citation: D. Khayat et al., FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL, Medicamentos de actualidad, 32, 1996, pp. 35-41
Citation: D. Khayat, WHAT IS THE ROLE OF VINDESINE IN NEOADJUVANT CHEMOTHERAPY, Journal of drug development and clinical practice, 7(3), 1995, pp. 141-150
Authors:
RIXE O
BOREL C
PARAISO D
BENHAMMOUDA A
PETIT T
ANTOINE E
BIZZARI JP
AUCLERC G
SOUBRANE C
WELL M
GIROUX B
BANZET P
KHAYAT D
Citation: O. Rixe et al., FOTEMUSTINE, DACARBAZINE, VINDESINE COMBINATION CHEMOTHERAPY IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF 43 PATIENTS, Melanoma research, 5(6), 1995, pp. 419-424
Authors:
PERETZ T
SULKES A
CHOLLET P
GELMON K
PARIDAENS R
GORBONUVA V
CATIMEL G
KUHNLE H
HUININK WTB
KHAYAT D
DITTRICH C
KLAASSEN U
BERGH J
WILKING N
NABHOLTZ JM
CALABRESI F
TUBIANAHULIN M
CHAZARD M
GALLANT G
DIERGARTEN K
WESTBERG R
BOGAERT J
RENARD J
WEIL C
Citation: T. Peretz et al., A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 31A, 1995, pp. 345-345
Authors:
BONNETERRE J
TUBIANAHULIN M
CHOLLET P
CHEVALLIER B
FUMOLEAU P
KERBRAT P
VIE B
KHAYAT D
TUBIANA N
LEJEUNE C
LEGRAND A
SOARES JA
PELLAECOSSET B
Citation: J. Bonneterre et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 354-354
Authors:
RIXE O
BENHAMMOUDA A
FARABOS C
BOREL C
PETIT T
AUCLERC G
COEFFIC D
BASTIAN G
GROSSIN F
PARAISO D
GRAPIN JP
NIZRI D
WEIL M
BISMUTH H
MAHJOUBI M
KHAYAT D
Citation: O. Rixe et al., A PHASE-I STUDY OF CONCOMITANT CPT-11 (C) AND 5FU (F) COMBINATION - PRELIMINARY-RESULTS, European journal of cancer, 31A, 1995, pp. 955-955
Authors:
LAMOUR A
BARON D
SOUBRANE C
CARTRON J
KHAYAT D
ADLER Y
LEGOFF P
YOUINOU P
Citation: A. Lamour et al., ANTI-FC-GAMMA RECEPTOR-III AUTOANTIBODY IS ASSOCIATED WITH SOLUBLE RECEPTOR IN RHEUMATOID-ARTHRITIS SERUM AND SYNOVIAL-FLUID, Journal of autoimmunity, 8(2), 1995, pp. 249-265
Authors:
MOUAWAD R
CALVEZ V
RIXE O
GHOUMARI A
VEROLA O
GARAPIN F
KHAYAT D
SOUBRANE CI
Citation: R. Mouawad et al., REGRESSION OF TRANSPLANTED MURINE MELANOMA AFTER VIRUS-FREE TRANSFER OF A SUICIDE GENE, The FASEB journal, 9(3), 1995, pp. 494-494
Authors:
ANTOINE EC
RIXE O
VUILLEMIN E
BENHAMMOUDA A
BOREL C
GHIRONZI GC
MULARONI E
FRANKS C
AUCLERC G
SOUBRANE C
BANZET P
WEIL M
KHAYAT D
Citation: Ec. Antoine et al., A PHASE-II STUDY OF TAMOXIFEN COMBINED WITH CISPLATIN-INTERLEUKIN-2 AND ALPHA-INTERFERON IN METASTATIC MELANOMA, American journal of clinical oncology, 18(5), 1995, pp. 421-424
Authors:
BECHEREL PA
CHOSIDOW O
BERGER E
MARTIN S
KHAYAT D
HERSON S
FRANCES C
Citation: Pa. Becherel et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE MANAGEMENT OFSEVERE ECTHYMA GANGRENOSUM RELATED TO MYELODYSPLASTIC SYNDROME, Archives of dermatology, 131(8), 1995, pp. 892-894
Authors:
HUTIN P
LAMOUR A
PENNEC YL
SOUBRANE C
DIEN G
KHAYAT D
YOUINOU P
Citation: P. Hutin et al., CELL-FREE FC-GAMMA RECEPTOR III IN SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH CLINICAL AND BIOLOGICAL FEATURES, International archives of allergy and immunology, 103(1), 1994, pp. 23-27
Authors:
RIXE O
BENHAMMOUDA A
ANTOINE E
PETIT T
TOURANI JM
BOREL C
FRANKS C
KALIF B
MOUSSEAU M
THOMAS A
BENSFIA S
NIZRI D
SOUBRANE C
HERRERA A
BIZZARI JP
AUCLERC G
WEIL M
BANZET P
KHAYAT D
Citation: O. Rixe et al., CHEMOIMMUNOTHERAPY OF METASTATIC MELANOMA - CISPLATIN, INTERLEUKIN-2 AND IFN-ALPHA IN 91 PATIENTS, Pathologie et biologie, 42(10), 1994, pp. 1080-1081